Jun 29, 2026 06:01AM
Jun 29, 2026 06:00AM
Jun 29, 2026 06:00AM
Jun 29, 2026 06:00AM
May 7, 2026 08:30AM
Mar 19, 2026 08:30AM
Mar 3, 2026 08:31AM Theravance Biopharma drug trial fails, company cuts costs 60%
Mar 3, 2026 08:30AM
Nov 20, 2025 11:00AM
Nov 20, 2025 11:00AM
Nov 19, 2025 06:00AM
Nov 10, 2025 04:05PM
Oct 29, 2025 06:00AM
Oct 27, 2025 06:00AM Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
Oct 14, 2025 06:02AM
Oct 14, 2025 06:00AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Sep 2, 2025 06:00AM
Aug 26, 2025 05:21AM
Aug 25, 2025 06:00AM Theravance Biopharma completes enrollment in phase 3 drug study
Aug 25, 2025 06:00AM
Aug 12, 2025 04:05PM
Jul 28, 2025 06:00AM
Jul 23, 2025 06:00AM
Jun 26, 2025 06:00AM
Jun 26, 2025 06:00AM
Jun 2, 2025 06:20AM Theravance Biopharma (TBPH) Sells Remaining Royalty Interest in Trelegy Ellipta to GSK (GSK) for $225M
Jun 2, 2025 06:00AM
May 13, 2025 06:00AM
May 9, 2025 12:00PM
May 8, 2025 04:05PM
Apr 28, 2025 06:00AM
Apr 24, 2025 06:00AM
Apr 7, 2025 03:55PM Theravance Biopharma Presents Two New Ampreloxetine Analyses in Oral Session at the American Academy of Neurology 2025 Annual Meeting
Mar 31, 2025 06:00AM
Mar 27, 2025 06:00AM
Feb 26, 2025 04:05PM
Feb 20, 2025 06:00AM
Feb 12, 2025 06:00AM
Feb 5, 2025 06:00AM
Dec 17, 2024 06:00AM Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
Nov 20, 2024 06:00AM
Nov 12, 2024 04:05PM
Oct 24, 2024 06:00AM
Oct 18, 2024 09:02AM
Oct 18, 2024 09:00AM
Aug 27, 2024 06:00AM
Aug 5, 2024 04:05PM Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
Jul 25, 2024 06:00AM

325,726 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All